跳至主要内容
临床试验/NCT02027246
NCT02027246撤回1 期

Autologous Bone Marrow Mononuclear Cell Therapy for Spinal Cord Injury

Neurogen Brain and Spine Institute2 个研究点 分布在 1 个国家开始时间: 2008年12月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
撤回
试验地点
2
主要终点
Change in clinical symptoms

研究概览

简要总结

The aim of this study was to study the effect of stem cell therapy on common symptoms of spinal cord injury patients.

详细描述

Autologous bone marrow mononuclear cells are administered intrathecally by a standard procedure followed by standard rehabilitation therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
8 Months 至 63 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed cases of any type of chronic Spinal cord injury
  • Age above 6 months

排除标准

  • presence of acute infections such as Human immunodeficiency virus/ Hepatitis B Virus/ Hepatitis C Virus
  • malignancies
  • bleeding tendencies
  • pneumonia
  • renal failure
  • severe liver dysfunction
  • severe anemia [Hemoglobin < 8]
  • any bone marrow disorder
  • other acute medical conditions such as respiratory infection
  • pregnancy and lactation

研究组 & 干预措施

Stem cell

Experimental

Autologous bone marrow mononuclear cell transplantation

干预措施: Autologous bone marrow mononuclear cell transplantation (Biological)

结局指标

主要结局

Change in clinical symptoms

时间窗: 6 months

clinical symptoms were assessed based on the observation of the experts

次要结局

  • Functional Independence Measure (FIM)(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验